Transcriptional regulation of human polo-like kinases and early mitotic inhibitor.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of genetics and genomics = Yi chuan xue bao

• Publication date

  2008-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1673-8527(08)60030-2PMID 18439978
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polo-like kinase 3 is required for entry into S phase

  2007cited by this paper
• Loss of Emi1-Dependent Anaphase-Promoting Complex/Cyclosome Inhibition Deregulates E2F Target Expression and Elicits DNA Damage-Induced Senescence

  2007cited by this paper
• Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells

  2007cited by this paper
• Epigenetic Inactivation Implies a Tumor Suppressor Function in Hematologic Malignancies for Polo-Like Kinase 2 but not Polo-Like Kinase 3

  2006cited by this paper
• The Anaphase-promoting Complex/Cyclosome Inhibitor Emi2 Is Essential for Meiotic but Not Mitotic Cell Cycles*

  2006cited by this paper
• Cytostatic factor: an activity that puts the cell cycle on hold

  2006cited by this paper
• Polo-Like Kinases: A Team in Control of the Division

  2006cited by this paper
• Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis.

  2006cited by this paper
• Polo-Like Kinase 1: Target and Regulator of Transcriptional Control

  2006cited by this paper
• Induction of tetraploidy through loss of p53 and upregulation of Plk1 by human papillomavirus type-16 E6

  2006cited by this paper
• JPO1/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity.

  2006cited by this paper
• The Polo kinase Plk4 functions in centriole duplication

  2005cited by this paper
• Polo-like kinases (Plks) and cancer

  2005cited by this paper
• A role for the anaphase-promoting complex inhibitor Emi2/XErp1, a homolog of early mitotic inhibitor 1, in cytostatic factor arrest of Xenopus eggs.

  2005cited by this paper
• Modulation of cell cycle components by epigenetic and genetic events.

  2005cited by this paper
• Interaction of Chromatin-associated Plk1 and Mcm7*

  2005cited by this paper
• SAK/PLK4 is required for centriole duplication and flagella development.

  2005cited by this paper
• Conditional E2F1 activation in transgenic mice causes testicular atrophy and dysplasia mimicking human CIS

  2005cited by this paper
• Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis

  2005cited by this paper
• Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues

  2005cited by this paper
• Regulation of Geminin and Cdt1 expression by E2F transcription factors

  2004cited by this paper
• Polo-like kinases and the orchestration of cell division

  2004cited by this paper
• Polo-like kinase-2 is required for centriole duplication in mammalian cells.

  2004cited by this paper
• E2Fs link the control of G1/S and G2/M transcription

  2004cited by this paper
• Hierarchical Requirement of SWI/SNF in Retinoblastoma Tumor Suppressor-mediated Repression of Plk1*

  2004cited by this paper
• Cell cycle-dependent regulation of the human aurora B promoter.

  2004cited by this paper
• Emi1-mediated M-phase arrest in Xenopus eggs is distinct from cytostatic factor arrest.

  2004cited by this paper
• E2F target genes: unraveling the biology.

  2004cited by this paper
• Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFbetaTrCP-dependent destruction of the APC Inhibitor Emi1.

  2004cited by this paper
• Cell Cycle Arrest and Apoptosis Induced by Human Polo-Like Kinase 3 Is Mediated through Perturbation of Microtubule Integrity

  2002cited by this paper
• E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APCCdh1

  2002cited by this paper
• Emi1 is required for cytostatic factor arrest in vertebrate eggs

  2002cited by this paper
• Identification of Promoter Elements Responsible for Transcriptional Inhibition of Polo-like Kinase 1 and Topoisomerase IIα Genes by p21WAF1/CIP1/ SDI1

  2002cited by this paper
• Emi1 regulates the anaphase-promoting complex by a different mechanism than Mad2 proteins.

  2001cited by this paper
• Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex.

  2001cited by this paper
• Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase

  2001cited by this paper
• A genome-wide survey of RAS transformation targets

  2000cited by this paper
• Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex

  1999cited by this paper
• Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F

  1999cited by this paper
• Cloning and characterization of human MCM7 promoter.

  1998cited by this paper
• Polo-like kinases: a team that plays throughout mitosis.

  1998cited by this paper
• Cell Cycle Regulation of the Human Polo-like Kinase (PLK) Promoter*

  1997cited by this paper
• E2F-1 functions in mice to promote apoptosis and suppress proliferation.

  1996cited by this paper
• Tumor induction and tissue atrophy in mice lacking E2F-1.

  1996cited by this paper
• The cellular effects of E2F overexpression.

  1996cited by this paper
• Identification and functional characterization of the human and murine polo-like kinase (Plk) promoter.

  1995cited by this paper
• Cell cycle analysis and chromosomal localization of human Plk1, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5.

  1994cited by this paper
• polo encodes a protein kinase homolog required for mitosis in Drosophila.

  1991cited by this paper
• Stabilization and enhancement of primary cytostatic factor (CSF) by ATP and NaF in amphibian egg cytosols.

  1988cited by this paper

• KMT2C inactivation leads to PTEN downregulation and tolerance to DNA damage during cell cycle progression

  2025cites this paper
• Cdk1 and PP2A constitute a molecular switch controlling orderly degradation of atypical E2Fs

  2025cites this paper
• Unraveling the genetic landscape of high-risk retinoblastoma through transcriptome profiling

  2025cites this paper
• The Role of Polo-Like Kinase 1 in Regulating the Forkhead Box Family Transcription Factors

  2023cites this paper
• Resistance to BRAF Inhibitors: EZH2 and Its Downstream Targets as Potential Therapeutic Options in Melanoma

  2023cites this paper
• Ethnic and racial-specific differences in levels of centrosome-associated mitotic kinases, proliferative and epithelial-to-mesenchymal markers in breast cancers

  2022cites this paper
• The role of Fbxo5 in the development of human malignant tumors.

  2022cites this paper
• E2F2 promotes lung adenocarcinoma progression through B-Myb- and FOXM1-facilitated core transcription regulatory circuitry

  2022cites this paper
• Targeting polo-like kinase 1 in pediatric leukemia

  2020cites this paper
• Loss of AMPKalpha1 Triggers Centrosome Amplification via PLK4 Upregulation in Mouse Embryonic Fibroblasts

  2020cites this paper
• MEK blockade overcomes the limited activity of palbociclib in head and neck cancer

  2020cites this paper
• The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?

  2019cites this paper
• Alterations in cellular and viral microRNA and cellular gene expression in Marek's disease virus‐transformed T‐cell lines treated with sodium butyrate

  2019cites this paper
• Two Transcripts of FBXO5 Promote Migration and Osteogenic Differentiation of Human Periodontal Ligament Mesenchymal Stem Cells

  2018cites this paper
• Mécanisme de contrôle de l'entrée en mitose par Polo-like kinase 1 (PlK1)

  2017cites this paper
• The E2F activators control multiple mitotic regulators and maintain genomic integrity through Sgo1 and BubR1

  2017cites this paper
• In Vitro Exposure of Human Luteinized Mural Granulosa Cells to Dibutyl Phthalate Affects Global Gene Expression

  2017cites this paper
• Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer

  2017cites this paper
• Polo-like kinase 1 expression is suppressed by CCAAT/enhancer-binding protein α to mediate colon carcinoma cell differentiation and apoptosis.

  2017cites this paper
• Exploration of Mutation and DNA Methylation of Polo-Like Kinase 1 (PLK1) in Colorectal Cancer

  2017cites this paper
• Molecular interactions of polo-like kinase 1 in human cancers

  2016cites this paper
• Polo-Like Kinase 1 and Smooth Muscle Cells in Coronary Artery Bypass Conduits and Coronary Arteries Following Angioplasty

  2016cites this paper
• Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models

  2016cites this paper
• FOXM1 participates in PLK1-regulated cell cycle progression in renal cell cancer cells.

  2016cites this paper
• Transcriptional Control of Mitosis: Deregulation and Cancer

  2015influential citation
• Cross-Talk between AURKA and Plk1 in Mitotic Entry and Spindle Assembly

  2015cites this paper
• Silencing of E2F3 suppresses tumor growth of Her2+ breast cancer cells by restricting mitosis

  2015cites this paper
• Thymosin Beta‐4 Knockdown in IEC‐6 Normal Intestinal Epithelial Cells Induces DNA Re‐replication Via Downregulating Emi1

  2014cites this paper
• E2F Activators Signal and Maintain Centrosome Amplification in Breast Cancer Cells

  2014cites this paper
• PLK4 overexpression and its effect on centrosome regulation and chromosome stability in human gastric cancer

  2014cites this paper
• University of Birmingham Inhibition of Plk1 and Cyclin B1 expression results in panobinostat-induced G delay and mitotic defects

  2013cites this paper
• Inhibition of Plk1 and Cyclin B1 Expression Results in Panobinostat-Induced G2 Delay and Mitotic Defects

  2013cites this paper
• Unbiased transcriptome signature of in vivo cell proliferation reveals pro- and antiproliferative gene networks

  2013cites this paper
• p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex.

  2013cites this paper
• Inhibition of Plk1 and Cyclin B1 expression results in panobinostat-induced G delay and mitotic defects G and

  2013cites this paper
• The role of polo-like kinase 1 in carcinogenesis: cause or consequence?

  2013cites this paper
• The Role of free- and liposomal-N-acetycysteine in paraquat-induced cytotoxicity

  2012cites this paper
• Pathways for Genome Integrity in G2 Phase of the Cell Cycle

  2012cites this paper
• Arabidopsis ULTRAVIOLET-B-INSENSITIVE4 Maintains Cell Division Activity by Temporal Inhibition of the Anaphase-Promoting Complex/Cyclosome[C][W]

  2011cites this paper
• Characterization of kinases involved in the phosphorylation of aggregated α‐synuclein

  2011cites this paper
• The Effects of Polo-like Kinase 4 on Chromosomal Stability, Cell Migration and Tumourigenesis

  2011cites this paper
• The polo-like kinase inhibitor BI 2536 exhibits potent activity against malignant plasma cells and represents a novel therapy in multiple myeloma.

  2011cites this paper
• Escape from p21-mediated Oncogene-induced Senescence Leads to Cell Dedifferentiation and Dependence on Anti-apoptotic Bcl-xL and MCL1 Proteins*

  2011cites this paper
• Regulación de la quinasa VRK1 por Plk3 y su implicación en la dinámica del aparato de Golgi en división celular

  2010cites this paper
• Activators Signal and Maintain Centrosome Amplification in Breast Cancer Cells

  year unknowncites this paper